Company / Assets per Share
BridgeBio Pharma, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.93
FY2025
5-year range
$3.63 / $8.24
FY2021-FY2025
Trend
-6.2%
vs FY2024
Sector context
#149 of 210
Health Care
What the data says
At $4.93, BridgeBio Pharma, Inc.'s assets per share ranks #149 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 8 years, ranging from $3.63 in FY2023 to $8.24 in FY2021.
Based on SEC 10-K filings.
4.93 in FY2025 with a 5-year CAGR of -2.8%.
Improved from $3.63 to $4.93 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
#149 of 210 in Health CareTop 71% of 210This company $4.93 Sector average $296.79
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 6.2% year-over-year.
- Ranks #149 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.93 | -6.2% |
| FY2024 | $5.25 | +44.8% |
| FY2023 | $3.63 | -14.2% |
| FY2022 | $4.23 | -48.7% |
| FY2021 | $8.24 | +44.9% |
| FY2020 | $5.69 | -17.1% |
| FY2019 | $6.86 | -8.8% |
| FY2018 | $7.53 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026